Basel Medical Group Ltd (BMGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 262 | -9,832 | -232 | 1,774 |
| Depreciation Amortization | 149 | 85 | 15 | 22 |
| Accounts receivable | -982 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,255 | N/A | N/A | N/A |
| Other Working Capital | -3,116 | -2,556 | -2,614 | -4 |
| Other Operating Activity | 4,667 | 8,888 | 57 | 59 |
| Operating Cash Flow | $-1,276 | $-3,415 | $-2,774 | $1,852 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -97 | -43 | -13 | -6 |
| Net Acquisitions | 0 | -8,638 | N/A | 0 |
| Other Investing Activity | 5 | 0 | 40 | 0 |
| Investing Cash Flow | $-93 | $-8,681 | $26 | $-6 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 2,333 | N/A | N/A | N/A |
| Debt Repayment | -96 | N/A | N/A | N/A |
| Other Financing Activity | -2,522 | 13,294 | 6,779 | -1,304 |
| Financing Cash Flow | $-285 | $13,294 | $6,779 | $-1,304 |
| Exchange Rate Effect | 331 | -390 | -9 | 0 |
| Beginning Cash Position | 2,368 | 1,534 | 1,428 | 898 |
| End Cash Position | 1,045 | 2,342 | 5,450 | 1,440 |
| Net Cash Flow | $-1,323 | $808 | $4,022 | $541 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,276 | -3,415 | -2,774 | 1,852 |
| Capital Expenditure | -97 | N/A | N/A | N/A |
| Free Cash Flow | -1,373 | -3,415 | -2,774 | 1,852 |